Venture capitalists shift away from biotech in first quarter

Venture capitalists shifted priorities from biotechnology to Internet companies in the first quarter of 2005, according to a survey by VentureOne and Ernst & Young. Investment levels have remained steady at $4.5 billion to $5 billion over the past couple of years, but investment in biotech dropped to $657 million, down from more than $1 billion during the fourth quarter of 2004.

View Full Article in:

San Jose Mercury News (Calif.) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC